Article
Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
The Journal of dermatology - 1 Jun 2011
Assmann Gunter, Pfoehler Claudia, Simon Pierre, Pfreundschuh Michael, Tilgen Wolfgang, Wieczorek Stefan
Abstract excerpt
Psoriasis (Ps) and psoriatic arthritis (PsA) are diseases of unknown origin. However, the receptor activator nuclear factor κ B ligand (RANKL) might play a key role in the pathomechanisms of the disease. Our aim was to study seven single nucleotide polymorphisms (SNP) in the genes encoding for re...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.